Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions

$BLLNPress releaseAug 18, 2026, 12:08 PM ETRead the release

BillionToOne announced the publication of the largest prospective study evaluating cfDNA fetal risk assessment in general-risk pregnancies in *The Green Journal*. The study of 2,212 pregnant carriers demonstrated that the Unity Fetal Risk Screen achieved 94.4% sensitivity and 99.5% specificity, identifying more affected pregnancies than traditional carrier screening.

Key figures

Sensitivity
94.4%
Specificity
99.5%
Outcome rate
98.6%
Study participants
2212
Negative predictive value
>99.9%

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.